Irish Medical TimesFRAX the more clinically relevant measureIrish Medical TimesA study of Irish prescribing patterns identified that the longer a patient was prescribed the corticosteroid prednisolone, the greater the likelihood of subsequently being p…
Bionomics Limited : BNC105 RENAL CANCER TRIAL DATA PRESENTED AT ASCO-GU4-traders (press release)Bionomics is conducting a US multi-centre Phase II clinical trial of BNC105 in combination with everolimus (Afinitor) in patients with metastatic Renal Cell…
Limerick BioPharma aims to prevent organ rejection, treat cause of diabetesMedCity NewsThe first of Limerick BioPharma's lead candidates, LIM-0705, is designed to improve the safety of existing immunosuppressive drugs used to prevent organ rejectio…
Medgadget.comBoston Sci's PROMUS Element Plus PtCr Stent Debuts in EuropeMedgadget.comby Brian Klein on Feb 2, 2012 • 4:45 pm Bostton Scientific has announced the European market launch of the PROMUS Element Plus everolimus-eluting platinum chrom…
InPharmZytiga cost too high, says NICEInPharmZytiga (abiraterone) is not recommended, in combination with steroids prednisone or prednisolone, as a second-line treatment for metastatic, castration-resistant prostate cancer in patients who have failed o…
Biomedical Scientist Job Biochemistry LondonMediplacementsManual tests performed include – Sirolimus, Cyclosporin and Tacrolimus with Mass Spec; Protein Electrophoresis – screening and fixing with Sebia Hydrasys. • Maintaining quality control of …
Boston Scientific Announces First Implant and Market Launch of PROMUS Element …Sacramento Bee1, 2012 — /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) announces first patient use and European market launch of the PROMUS Element™ Plus Eve…
Boston Scientific Unveils European Market Launch Of PROMUS Element PlusNASDAQ(BSX) announced first patient use and European market launch of the PROMUS Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System. The company said the new st…
Don't Fret About Taking AdvairdailyRxIn a new study, a combined treatment of Long-acting β-agonists (LABAs) and inhaled corticosteroids (ICS) were shown to be as safe as inhaled corticosteroids. The combined LABAs/ICS therapy was proven to be as e…
Preop evaluation before refractive IOL implantationModernMedicineThis patient was treated preoperatively with a topical prednisolone acetate 1% and cyclosporine (Restasis, Allergan), which, 1 week later, resulted in more consistent astigmatism measurem…